Cell Impact (CI.ST) Stock Analysis & AI Equity Report

Manufacturing - Metal Fabrication SEK Explore free reports

Cell Impact (CI.ST) overview

Cell Impact (CI.ST) stock analysis and AI equity research. For the latest completed financial year, 2024, Cell Impact reported revenue of SEK 37.3m and operating profit of SEK -99.0m; the year-end share price was 1.43 SEK and market capitalisation was SEK 884m. Cell Impact is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Cell Impact's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueSEK 219mFY 2024
Share price1.43 SEKFY 2024 year end
RevenueSEK 37.3mFY 2024
Operating profitSEK -99.0mFY 2024
Net earningsSEK -101mFY 2024
Market capitalisationSEK 884mFY 2024 year end

Figures updated on 2025-09-05. Data will be refreshed during report generation.

About Cell Impact

Cell Impact AB develops and manufactures flow plates for fuel cells and electrolyzers, using its patented Cell Impact Forming technology. The company also provides design services, tools, prototype series, and production equipment linked to these applications. Its offerings are aimed at industrial customers in the hydrogen value chain and related metal forming uses.

Generate the Cell Impact report

Cell Impact is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, typically within about 30 minutes

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Cell Impact and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.